Undisclosed anti LAG3/PD-1 BsAb
/ Fontacea
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2023
Oncology Innovations: LAG3 Inhibition in Melanoma Treatment
(Healio)
- "Release date: September 15, 2023; Expiration date: September 14, 2024; Upon completion of this activity, participants should be able to: Assess the efficacy and safety of anti-LAG-3/PD-1 combination regimens (approved and under investigation) for patients with metastatic melanoma, Discuss the role for dual LAG-3/PD-1 checkpoint blockade regimens in treatment plans for patients with metastatic melanoma."
Online CME
1 to 1
Of
1
Go to page
1